Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HSV-2”

85 trials

Showing 20 of 85 results

Early research (Phase 1)Enrolling By InvitationNCT07330440
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination

Who this might be right for
Genital Herpes
Changchun BCHT Biotechnology Co. 144
Large-scale testing (Phase 3)Study completedNCT00209313
What this trial is testing

Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon

Who this might be right for
HIV-1 and HSV-2 CoinfectionHIV Infections
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT01501864
What this trial is testing

School Support as Structural HIV Prevention for Adolescent Orphans in Kenya

Who this might be right for
HIV
Pacific Institute for Research and Evaluation 835
Not applicableStudy completedNCT03701802
What this trial is testing

Immunogenetic Modulators of Mucosal Protection From HIV-1

Who this might be right for
HIV InfectionsHSV-2 Infection
University of Washington 812
Testing effectiveness (Phase 2)Study completedNCT00371592
What this trial is testing

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

Who this might be right for
HIV InfectionsHerpesvirus 2, Human
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT00310271
What this trial is testing

A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects

Who this might be right for
HSV-2
PowderMed 42
Not applicableWithdrawnNCT00682721
What this trial is testing

Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive Women

Who this might be right for
Bacterial VaginosisHerpes Simplex Virus Type II
University of Pittsburgh
Large-scale testing (Phase 3)Study completedNCT00465205
What this trial is testing

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

Who this might be right for
HIV InfectionsHerpes SimplexSexually Transmitted Diseases
University of Washington 20
Large-scale testing (Phase 3)Study completedNCT01386294
What this trial is testing

Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

Who this might be right for
HIV Prevention
CONRAD 2,059
Not applicableStudy completedNCT01112956
What this trial is testing

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

Who this might be right for
Genital Herpes
Centers for Disease Control and Prevention 2,500
Testing effectiveness (Phase 2)UnknownNCT03595995
What this trial is testing

Trial to Evaluate the Safety and Efficacy of UB-621

Who this might be right for
Genital Herpes
United BioPharma 80
Not applicableStudy completedNCT04205721
What this trial is testing

Impact Evaluation of a School-Based Sexuality and HIV Prevention Education Activity in South Africa

Who this might be right for
HSV-2 InfectionHIV InfectionsPregnancy Related
University of North Carolina, Chapel Hill 23,061
Not applicableStudy completedNCT03868644
What this trial is testing

The Impact of VCT and Condom Distribution as HIV Prevention Strategies Among Youth in Kenya

Who this might be right for
HIV/AIDSHSV-2 Infection
Abdul Latif Jameel Poverty Action Lab 10,646
Large-scale testing (Phase 3)Study completedNCT00164424
What this trial is testing

Episodic Acyclovir Therapy for Genital Ulcers

Who this might be right for
HIV InfectionsUlcerHerpes Simplex
Centers for Disease Control and Prevention 613
Not applicableStudy completedNCT03080961
What this trial is testing

The VIBLOK SAfety and perFormancE Trial

Who this might be right for
HSV-2 InfectionGenital Herpes
CLJI Worldwide 82
Post-approval studies (Phase 4)Study completedNCT00306293
What this trial is testing

VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2

Who this might be right for
Herpes Labialis
GlaxoSmithKline 70
Post-approval studies (Phase 4)Ended earlyNCT00495716
What this trial is testing

Effect of HSV-2 Suppressive Therapy on Sexual Behavior

Who this might be right for
Genital Herpes
University of Washington 72
Large-scale testing (Phase 3)Study completedNCT00378976
What this trial is testing

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.

Who this might be right for
HIV InfectionHerpes SimplexSexually Transmitted Diseases
University of Washington 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT05452928
What this trial is testing

Aciclovir Versus Placebo for HSV-2 Meningitis

Who this might be right for
Herpes Simplex 2Meningitis, Viral
Jacob Bodilsen 150
Testing effectiveness (Phase 2)Study completedNCT02114060
What this trial is testing

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 310
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation